semaglutide
Commercial- Indications
- Weight management, Obesity
Company intelligence / Profile preview
Henry Meds
San Francisco, California, United Stateshenrymeds.com ↗
- Ownership
- Private
- Employees
- ~477
- Development stage
- Commercial
01
Overview
Henry Meds operates a commercial telemedicine platform offering weight management and hormone replacement therapy. It provides compounded versions of popular GLP‑1 receptor agonists such as semaglutide, liraglutide, and tirzepatide for weight loss, as well as testosterone therapies for low testosterone. The company focuses on accessibility by offering oral and injectable options at subscription pricing without requiring insurance coverage. No clinical trial results are published; the company dispenses FDA-approved or compounded medications.
- Therapeutic areas
- Endocrinology
- Modalities
- Small moleculeHormonePeptidesBiologic
- Industry
- Non-Academic Healthcare
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Henry Meds.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Henry Meds.